Ziyan Y. Pessetto - Concepedia

Author

Ziyan Y. Pessetto

University of Kansas Medical Center ORCID

Also Known As

Ziyan Pessetto, Ziyan Y Pessetto, Ziyan Y. Pessetto, Ziyan Yuan Pessetto

Publications

711

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center The University of Kansas Cancer Center University of Kansas University of California, San Francisco

About

Ziyan Y. Pessetto is an author at University of Kansas Medical Center specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	343
2	Cell Biology	3	3	125
3	Biomedical Engineering	1	1	28
4	Blood Transplantation	1	1	23
5	Cellular Physiology	1	1	71

Ziyan Y. Pessetto

Publications

674

Citations

H-Index

Page 1

	Year	Citations
High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study Kishore Polireddy, Ruochen Dong, Gregory A. Reed, Scientific Reports	2017	141
Drug Repurposing for Gastrointestinal Stromal Tumor Ziyan Y. Pessetto, Scott J. Weir, Geetika Sethi, Molecular Cancer Therapeutics ImmunologyGastroenterologyPharmacotherapyReactive Oxygen SpeciesTumor Biology	2013	93
WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1 Meizhang Li, Rupal P. Soder, Sunil Abhyankar, Journal of Extracellular Vesicles Cell TherapyImmunologyPathologyImmunologic MechanismExtracellular Microvesicles	2021	71
Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties Jeff Hirst, Harsh B. Pathak, Stephen Hyter, Cancer Research	2018	49
<i>In silico</i> and <i>in vitro</i> drug screening identifies new therapeutic approaches for Ewing sarcoma Ziyan Y. Pessetto, Bin Chen, Hani Alturkmani, Oncotarget Drug ActivityTumor BiologyEwing SarcomaIntegrated Bioinformatics ApproachMalignant Disease	2016	47
Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option Ziyan Y. Pessetto, Ying Yan, Tadayoshi Bessho, Breast Cancer Research and Treatment Breast OncologyMedicineBreast Cancer CellsPharmacology-Phosphoprotein Interaction	2012	40
Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor Ziyan Y. Pessetto, Yan Ma, Jeff Hirst, Molecular Cancer Therapeutics	2014	33
Nano pom-poms prepared exosomes enable highly specific cancer biomarker detection Nan He, Sirisha Thippabhotla, Cuncong Zhong, Communications Biology	2022	31
Microfluidic affinity selection of active SARS-CoV-2 virus particles Sachindra S. T. Gamage, Thilanga N. Pahattuge, Harshani Wijerathne, Science Advances VaccinationViral DiagnosticsSynthetic VirologyViral PathogenesisVirology	2022	28
Role of miR-139 as a surrogate marker for tumor aggression in breast cancer Hongyan Dai, D. S. Gallagher, Sarah Schmitt, Human Pathology Breast OncologyOncologyMedicineSurrogate MarkerPathology	2016	27

Page 1